ReviewClinical, cosmetic and investigational dermatology2026
Evaluating the Top Interdisciplinary Authors in Dermatology and Immunology Through Decadal Trend H-Index Analysis of 1980-2024.
Review in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Previous bibliometric analyses focus on primary specialty, potentially overlooking authors whose contributions span multiple disciplines. Given the increasing recognition of dysregulated immunological processes in dermatological conditions and the targeting of immune pathways in therapeutics, this study aims to evaluate the h-index of authors in both dermatology and immunology, capturing the multifaceted research landscape of dermatology and providing a comprehensive assessment of scholarly impact. Methods: A search of the Web of Science (WOS) schema from 1980 to 2024 was conducted using the InCites dataset, limited to original articles, editorial materials, and meeting abstracts, and authors were ranked by InCites h-index. Results: Over the past 5 years, the top 20 authors by InCites h-index in dermatology and immunology research were 65% males and 35% females, with USA (30%), Germany (20%), and France (15%) representing the highest proportions of authors. The trends across decades showed increased representation of female authors, presence of institutions outside the United States, and cross-disciplinary productivity in dermatology and immunology. Conclusion: The cross-disciplinary associations in dermatology underscore the utility of the h-index in assessing scholarly impact across multiple fields. The observed growth in interdisciplinary productivity and global representation among leading authors reflects translational research exploring immune pathways and molecular profiles that have driven the advancement and translational revolution of immunology-based therapies in dermatology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.